Small G proteins are expressed ubiquitously in lymphoid cells and do not correspond to Bcl-2

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Nature

• Publication date

  1990-07-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/346189A0PMID 2114553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro.

  1990cited by this paper
• A ras-related gene with transformation suppressor activity.

  1989cited by this paper
• Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein.

  1989cited by this paper
• The bcl-2 gene encodes a novel G protein

  1989cited by this paper
• Deregulated BCL2 expression enhances growth of a human B cell line.

  1989cited by this paper
• Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.

  1989cited by this paper
• bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

  1989cited by this paper
• Structural and functional properties of ras proteins

  1989cited by this paper
• The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

  1989cited by this paper
• Identification of a platelet Mr 22,000 GTP-binding protein as the novel smg-21 gene product having the same putative effector domain as the ras gene products.

  1988cited by this paper
• Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region.

  1988cited by this paper
• Oncogenic potential of bcl-2 demonstrated by gene transfer

  1988cited by this paper
• Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.

  1988cited by this paper
• Identification of novel GTP‐binding proteins in the human neutrophil

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

  1987cited by this paper
• Specific binding of [alpha-32P]GTP to cytosolic and membrane-bound proteins of human platelets correlates with the activation of phospholipase C.

  1987cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP‐binding and transforming activities.

  1986cited by this paper
• Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas

  1986cited by this paper
• The ral gene: a new ras related gene isolated by the use of a synthetic probe.

  1986cited by this paper
• G proteins: a family of signal transducers.

  1986cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• On the nature of crossreactions observed with antibodies directed to defined epitopes.

  1982cited by this paper
• Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

  1982cited by this paper
• Chromosome abnormalities in poorly differentiated lymphocytic lymphoma.

  1979cited by this paper
• DIAGNOSTIC ERRORS

  1955cited by this paper

• Advances in Brief Role of bcl-2 in Growth Factor Triggered Signal Transduction 1

  2006cites this paper
• Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis.

  1999cites this paper
• The Bcl-2 protein family.

  1999cites this paper
• The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy.

  1997cites this paper
• Apoptosis: molecular regulation of cell death.

  1996cites this paper
• Apoptosis: molecular regulation of cell death.

  1996cites this paper
• Regulation of lymphocyte survival by the bcl-2 gene family.

  1995cites this paper
• Several small GTP‐binding proteins are strongly down‐regulated in simian virus 40 (SV40) transformed human keratinocytes and may be required for the maintenance of the normal phenotype

  1994cites this paper
• [The BCL2 gene, prototype of a gene family that controls programmed cell death (apoptosis)].

  1994cites this paper
• Mapping small GTP‐binding proteins on high‐resolution two‐dimensional gels by a combination of GTP binding and labeling with in situ periodateoxidized GTP

  1994cites this paper
• Labeling of adenine and guanine nucleotide-binding proteins in permeabilized cells with in situ periodate-oxidized nucleotides.

  1993cites this paper
• Bcl-2 associates with the ras-related protein R-rasp23

  1993cites this paper
• BCL-2: physiology and role in neoplasia.

  1992cites this paper
• BCL2 gene: current relevance to clinical oncology.

  1992cites this paper
• Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.

  1992cites this paper
• bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

  1992cites this paper
• Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms

  1992cites this paper
• From genes to antibodies: the antipeptide approach to the immunocytochemical study of human malignant lymphoproliferative diseases.

  1991cites this paper
• PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1

  1991cites this paper
• The bcl-2 gene and protein in malignant lymphomas.

  1991cites this paper
• High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients

  1991cites this paper
• Molecular biology of lymphoid malignancies.

  1991cites this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cites this paper
• Role of bcl-2 in growth factor triggered signal transduction.

  1990cites this paper
• The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.

  1990cites this paper